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Abstract:
Background: Genetic polymorphisms that affect the production levels of  certain cytokines and/or their receptors may deter-
mine the risk, severity or protection in some infectious diseases like brucellosis.
Objectives: The aim of  this study was to investigate the association of  certain known Interferon-γ Receptor-1 (IFN-γ R1) gene 
promoter polymorphisms and the susceptibility to infection with Brucellosis in Saudi population.
Methods: A cases-control association study was conducted in 69 individuals with human brucellosis and 94 healthy individuals. 
Genotyping of  IFN-γ R1 – 56 C>T and IFN-γ R1 – 611 A>G polymorphism in both patients and healthy controls was done 
by PCR- restriction enzyme length polymorphisms (PCR-RFLP) and PCR- confronting two primer pairs (PCR-CTPP) methods 
and were assessed for potential associations with susceptibility for human brucellosis and their mode of  penetrance.
Results: Interestingly, we have designed a PCR-CTPP system to be used for genotyping of     IFN-γ R1 – 611 A > G polymor-
phism. The PCR-CTPP is an accurate method for genotyping of  SNPs. Moreover, it is time-saving, inexpensive and easy to 
perform.
Conclusion: Both tested polymorphisms, IFN-γ R1 – 56 C>T and IFN-γ R1 -611 A>G polymorphism had no role in genetic 
susceptibility to human brucellosis in the study population. The PCR-CTPP can be used for genotyping IFN-γ R1 – 611 A > G 
polymorphism and other types of  mutation.
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Introduction
Brucellosis is one of  the most common zoonotic diseas-
es in the world that is mainly endemic in Middle East, 
Africa, Asia and Central and South America and is as-
sociated with significant health problems and economic 
losses1. The etiological agents of  brucellosis are Brucella 
species that are small, Gram-negative, aerobic, facultative 
intracellular, coccobacilli bacteria and cause undulant fe-
ver, endocarditis, arthritis, and osteomyelitis in humans 
and abortion and temporary infertility in domestic ani-
mals2. In Saudi Arabia, human brucellosis has emerged 
as a major public health problem with increasing rates 
of  annual admissions for brucellosis3.  This increasing in 
incidence rates of  brucellosis had been strongly linked 
to the uncontrolled importation of  potentially infected 
animals with brucellosis, widespread cattle breeding, and 
the prevailing habit of  ingesting raw milk or its products 
among the population with a nomadic background4. Bru-
cella organisms infect cells of  the reticuloendothelial sys-
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tem and can be sequestered in at specific locations with-
in the body, such as brain, heart, spleen, joints, liver and 
bone marrow5.
Human protective immune response against Brucella 
infection depends on cell-mediated immunity involving 
mainly activated antigen-presenting cells (macrophages, 
dendritic cells) and CD4+ and CD8+ T lymphocytes6. 
Upon encounter with Brucella antigens, antigen present-
ing cells (APC) produce cytokines such as Interleukin 
(IL)-23, IL-1β, IL-18, IL-12 and TNF via the stimula-
tion of  pattern recognition receptors, including Toll-like 
receptors7. Type-1 helper T (Th1) cells and natural kill-
er (NK) cells express receptors for these cytokines and 
produce Interferon-γ (IFN-γ) in response to IL-12 or 
IL-23, which can be enhanced by IL-1β and IL-18. The 
IFN-γ is a pleiotropic cytokine playing a central role in 
type-1 immunity against intracellular pathogens such as 
Brucellosis, Mycobacteria and Salmonellae and up-reg-
ulates macrophage killing mechanisms by induction of  
superoxide anions and hydrogen peroxide8. The IFN-γ, 
in turn, binds to the IFN-γ receptor (IFN-γ R) which is 
made up of  a and b subunits, both of  which are integral 
membrane proteins and present on nearly all cell types. 
The α sub-unit (encoded by the gene IFN-γ R1) plays 
a critical role in ligand binding, receptor trafficking, and 
signal transduction9. APCs, including  monocytes, macro-
phages and Dendritic cells (DCs), are activated by IFN-γ 
to produce increased levels of  IL-12 and to enhance both 
antigen presentation and bactericidal activity10. Further, 
IFN-γ, depending on cell type, can block proliferation 
and induce apoptosis of  infected cells or enhance expres-
sion of  cell surface molecules such as HLA Class I and 
II, CD54 and CD64. The IFN-γ R is comprised of  two 
ligand-binding IFN-γR1 chains associated with two sig-
nal-transducing IFN-γ R2 chains. Binding of  IFN-γ to 
its receptor induces receptor oligomerization and activa-
tion of  the receptor-associated Janus kinases, JAK1 and 
JAK2, by trans-phosphorylation. 
The JAKs phosphorylate the tyrosine 440 that is part of  
the signal transducer and activator of  transcription pro-
tein1 (STAT1) docking site in the intracellular domain of  
the IFN-γ R1 and subsequent STAT1 phosphorylation. 
Phosphorylated STAT1 dissociates from the receptor, 
dimerizes and translocates to the nucleus, where it reg-
ulates the expression of  IFN-γ responsive genes direct-
ly or indirectly via the induction of  other transcription 
factors such as IRF1, IRF7 and CIITA11,12. STAT1 is the 
main mediator of  IFN-γ responses although, IFN-γ was 
reported to induce STAT3 or STAT5 phosphorylation in 
a few other cell types13.
In the IFN-γ R1 several amino acid substitutions have 
been reported that abrogate IFN-γ signaling. These sub-
stitutions can lead to a null phenotype and enhanced sus-
ceptibility to infection by low pathogenic mycobacteria 
and salmonellae, a disorder known as Mendelian Suscep-
tibility to Mycobacterial Diseases (MSMD)14,15. Several 
potentially functional single nucleotide polymorphisms 
(SNPs) have been identified in the human IFN-γ R1 
gene promoter. Few studies investigated the association 
between IFN-γ R1 gene polymorphisms and risk of  in-
fectious diseases. Previously, we studied the protective 
role of  TNF-α-857C/T and TNF-α-308A polymorphism 
against human brucellosis16. This study aimed mainly 
(i) to determine the frequency of  the selected polymor-
phisms located in IFN-γ R1 gene promoter in patients 
and healthy individuals selected from the general popula-
tion of  Makkah Region, (ii) to determine the association 
of  IFN-γ R1 gene promoter polymorphisms and genetic 
susceptibility to Brucellosis among the selected popula-
tion and (iii) to develop a PCR- confronting two primer 
pairs (PCR-CTPP) system to be used for genotyping of  
IFN-γ R1 – 611 A > G polymorphism.
Materials and methods
Study design and selection of  patients and their con-
trols
A case-control prospective study was carried out to inves-
tigate the impact of  IFN-γ R1 polymorphisms on resis-
tance/susceptibility to human brucellosis disease among 
Saudi population at Makkah region. All patients who had 
been admitted to general hospitals during the period of  
study subject selection and were presenting with clinical 
signs and symptoms (e.g., fever, malaise, night sweating, 
weakness, weight loss, myalgia, splenomegaly, lymphade-
nophathy and arthralgia), suggestive of  active brucellosis 
were examined by specialists and confirmed by a posi-
tive serological test in a single high titers (≥ 1/160) of  
Standard Agglutination Test (SAT) and/or positive blood 
cultures. A group of  69 confirmed patients with active 
Brucellosis were selected, after their acceptance, to par-
ticipate in the study. Twenty-four (34.8%) of  the patients 
were females and 45 (65.2%) were males. Their age varied 
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from 12 to 77 years with a mean of  42±22.17 years. The 
patients were from different nationalities that were Sau-
di Arabian 52 (75.4%), Sudanese, 7 (10.1%), Egyptian 4 
(5.8%), Pakistanian, 4 (5.8%) and Indian, 2 (2.95%). A 
group of  controls composed of  94 healthy individuals 
with no history of  brucellosis and were matched for geo-
graphic area, age and sex and had the same risk of  expo-
sure for brucellosis with SAT ≤ 1/80. They were selected 
for the study after accepting to participate in the study. 
Blood (EDTA tube and plain tube) samples were col-
lected from all participants. The protocol was approved 
by the Hospital Ethics Committee and written informed 
consent was obtained from all participants.
 
Mutation analysis of  IFN-γ R1 gene polymorphisms 
in patients and control groups
Two polymorphisms located in the promoter of  IFN-γ 
R1 gene were selected for evaluation of  their relation to 
susceptibility for human brucellosis study population. 
Both polymorphisms are transition mutation. The first is 
a transition replacement of  cytosine to thiamin at posi-
tion -56 (rs2234711) in respect to transcription site. While 
the other, is transition replacement of  adenine for gua-
nine at position – 611 (rs1327474). Genomic DNA was 
extracted from peripheral blood leukocytes using stan-
dard methods as described by the manufacture (Micro-
mix660 DNA extraction kit, Talent, Italy). The quality of  
the isolated DNA had been checked by electrophoresis 
on 1% agarose gel, quantitated spectrophotometrically 
and stored at -20°C till further use.
Screening of  IFN-γ R1 -56 T > C polymorphisms by 
Restriction Enzyme Length Polymorphisms (RFLP)
A 306 bp DNA fragment flanking the polymorphic site 
was PCR amplified using 100ng of  genomic DNA in 
a total reaction volume of  30µl using the primer pair: 
IFN-γ R-56 F: 5`- TCCTCCCACACCCAgAAgTCC 
-3`and IFN-γ R -56 R: 5`- gCggTgCCCATCTCAgCCCT 
-3`. PCR condition as initial temperature 95 C˚ for 5 min-
ute, flowed by 35 cycles of  94 C˚ as melting temperature 
for one minute, 60C˚ as annealing temperature for one 
minute and 72 C˚ as extinction temperature, then final 
prolongation step at 72 C˚ for 5 minutes. The transition 
replacement of  cytosine to thiamin in position -56 create 
a new restriction site for Eco 47Щ. In a total volume 
of  15 µl, 5 µl PCR products was digested overnight with 
1µl Eco 47Щ enzyme and mixed with Buffer 3 10x, BSA 
50µg and demonized water. The Digested DNA were 
mixed with 5 µl loading dye before electrophoresis in 2% 
agarose gel and the gels were stained in 1µg/ml ethidium 
bromide solution for 10-15 minutes and visualized with 
UV light under GDS.
Interpretation of  digestion reaction electrophoresis 
profiles
The genotype was assigned according to the length of  ob-
tain fragments. Complete cleavage 306 bp PCR product 
into the 186 and 120 bp fragments is characteristic profile 
of  the homozygote mutant allele (CC), incomplete cleav-
age into 306 bp, 186 bp and 120 bp is of  the heterozygote 
(TC). While absence of  digestion is a characteristic of  the 
homozygote wild (TT).
Screening of  IFN-γ R1 – 611 A>G polymorphism by 
Confronting Two Primer Pairs (PCR-CTPP)
The principle of  PCR-CTPP is based on the fact that: the 
efficiency of  PCR amplification depends on the complete 
matching of  primer sequence at it's 3`end. Thus, any mis-
match at this end of  the primer will affect the PCR ampli-
fication system. Accordingly, PCR-CTPP genotyping sys-
tem needs four primers; two common primers flanking 
the polymorphic site one at each side, but with different 
length from the polymorphic site17. The other two, are 
allele specific primers and each primer had been designed 
to be absolutely complementary to one allele sequence 
specially at the 3` end of  the primer. We have designed a 
PCR-CTPP system to be used for genotyping of     IFN-γ 
R1 – 611 A > G polymorphism. Four primers were de-
signed for IFNγR1 – 611 A > G polymorphism PCR-
CTPP genotyping system.
IFNγR1- 611 OF: 5`- CTAACTCTTggACTTCACCTgg 
-3`
IFNγR1- 611 OR: 5`- gCACAAgCgCTgAAggACTTAg 
-3`
IFNγR1- 611 A: 5`- CAATTCAgTgTCAAAT-
CAgTTTCTT -3`
IFNγ R1- 611 G: 5`- CTCTTCATgAgAggCTgCTTg -3`
In the presence of  the of  A allele at position - 611 in the 
promoter of   IFN-γ R1 gene, IFN-γ R1- 611 A  primer 
worked to amplify with the primer IFN-γ R1- 611OR  to 
give a PCR fragment of  136 bp while in the presence 
of  the G allele at position, the primer IFN-γ R1- 611 G 
worked to amplify with the primer IFN-γ R1- 611 OF to 
give a PCR fragment of  261 bp. A third PCR product of  
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352bp may be obtained as a result of  the IFN-γ R1- 611 
OF and IFN-γ R1- 611 OR.  PCR product was electro-
phoresis in 2% agarose gel and the gels were visualized 
with UV light under GDS after being stained in 1µg/ml 
ethidium bromide solution for 10-15 minutes.
The genotypes were assigned according to obtained pro-
file; two bands of  352 and 284 bp would be assigned as 
homozygote G/G, Three bands 352, 284 and 136 bp as 
heteroyzote A/G while two bands of  352 and 136 bp 
would be assigned as homozygote A/A genotype.
Statistical analysis
The Statistical Package for the Social Science (SPSS for 
Windows 14) wasused for statistical analysis. T- Test was 
used for comparing the distribution of  a variable between 
cases and controls groups. The Chi-square test was ap-
plied in comparing of  categorical data. The magnitude of  
association of  the polymorphism different genotypes and 
alleles and susceptibility to Brucellosis in the study pop-
ulation were tested using Cochran - Armitage (CA) trend 
test and Odd ratios (ORs) and 95% confidence intervals 
(CIs) in different genetic models of  inheritance were cal-
culated. All P values of  less than 0.05 were considered 
significant.
Results
In the present study, two transition polymorphisms lo-
cated in the promoter of  IFN-γ R1 gene at nucleotides 
– 56 (replacement of  C by T) and – 611(replacement of  
A by G)  were selected for evaluation of  their relation 
to susceptibility for human brucellosis study population 
and were genotyped in 69 brucellosis cases and 94 healthy 
controls. Distributions and genotyping of  both polymor-
phisms in Brucellosis cases and healthy controls groups 
were done by PCR-RFLP and PCR-CTPP methods as 
showing in Fig. 1, 2, 3 and 4 respectively. Genotypes fre-
quencies of  IFN-γ R1 – 56 C>T polymorphism in Bru-
cellosis cases were 23 (33%) CC, 31 (45%) were CT and 
15 (22%) were TT genotypes while, in healthy control 23 
(24.5%) were CC, 54 (57.4%) were CT and 17 (18.1%) 
were TT. Considering IFN-γ R1 – 611 A>G polymor-
phism, Genotypes frequencies in Brucellosis cases were 
36 (52%) AA, 25 (36%) AG and 8 (12%) GG genotypes 
while, in healthy control 49 (51%) AA, 37 (39%) AG and 
10 (10%) GG. There are no significant differences in gen-
otypes or alleles frequencies of  both polymorphisms be-
tween Brucellosis cases and healthy controls groups.
Fig.1: IFN-γ R1 – 56 C>T polymorphism genotypes 









C/C C/T T/T Allele C Allele T
Cases Healthy controls
Fig.1: IFN-γ R1 – 56 C>T polymorphism genotypes 
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Fig.2: IFN-γ R1 – 611 A>G polymorphism genotypes and alleles 
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Fig.2: IFN-γ R1 – 611 A>G polymorphism genotypes and alleles 
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Fig. 3: Genotyping of IFN-γ R1 – 56 C>T polymorphism by PCR-RFLP
Lanes 1, 9 & 11 are homozygous for allele T and Lanes   2, 5 & 7 are homozygous for 
allele C while 3, 4, 6, 8 & 10 are heterozygous. Lane 12: A 100-bp DNA marker
Fig. 3: Genotyping of IFN-γ R1 – 56 C>T polymorphism by PCR-RFLP
Lanes 1, 9 & 11 are homozygous for allele T and Lanes   2, 5 & 7 are homozygous for 
allele C while 3, 4, 6, 8 & 10 are heterozygous. Lane 12: A 100-bp DNA arker
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Associations of  both polymorphisms with susceptibility 
for human brucellosis study population were assessed by 
Armitage trend test for its penetrance in different genet-
ic models of  inheritance; allelic, co-dominant, dominant, 
over dominant and recessive models (Table 1 and 2). Ac-
cordingly, non of  the tested models was consistent nor 
fit penetrance of  any of  the two polymorphisms. This 
concluded that both tested polymorphisms, IFN-γ R1 – 
56 C>T polymorphism and IFN-γ R1 – 611 A>G poly-
morphism had no rule in genetic susceptibility to human 
brucellosis in study population.
Fig.4: Genotyping of IFN-γ R1 – 611 A>G polymorphism by CTPP method
Lanes 1, 2, 4, 7, 9 & 10 are homozygous for allele A and Lanes   3, 5, 6 & 8 are 
heterozygous while only Lane 11 is homozygous for allele G. Lane 12: A 100-
bp DNA marker
Table 1:  Assessment of association of IFN-γ R1 – 56 C>T polymorphism and Brucellosis patients. 
 
Model Brucellosis patients (n = 69) 
Healthy 
control 
(n = 94) 
P value 
(Pearson) Odd ratio (95% CI) 
Codominant     
0.469 
  
C/C 23(33%) 23(24.5%)   
C/T 31(45%) 54(57.4%)   
T/T 15(22%) 17(18.1%) 0.916(0.579 – 1.400) 
Allelic effect 
C 0.56 0.53     
T 0.44 0.47 0.641 0.900 (0.579 – 1.400) 
Overdominant         
C/C-T/T 38(55.1%) 40(42.6%)   1.00 
C/T 31(45%) 54(57.4%) 0.133 0.574 (0.277 – 1.188) 
Recessive         
C/C - C/T 54(78%) 77(81.9%)   1.00 
T/T 15(22%) 17(18.1%) 0.561 0.795 (0.366 – 1.728) 
Dominant         
C/C 46(67%) 71(75.5%)   1.00 
C/T - T/T 23(33%) 23(24.5%) 0.214 0.648 (0.326 – 1.288) 
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Discussion
Resistance to Brucella has been mainly studied in mice 
and has shown that cytokines influence the outcome of  
the disease by regulation the immune response18. The 
capacity of  cytokine production differs among individ-
uals and correlates with the polymorphism in the cyto-
kine gene promoters19. Although few studies in human, 
patients with acute brucellosis displayed a Th1-type re-
sponse in contrast to those with chronic form who have 
diminished Th1 response in response to the Brucella spe-
cific antigens20. We have previously investigated the role 
of  TNF-α-308A andTNF-α-857C/T polymorphism in 
susceptibility to human brucellosis by conducting genetic 
association studies based on case-control clinical studies. 
Our findings indicated an increased risk of  TNF-α-308A 
allele for human brucellosis consistent with the recessive 
genetic model of  penetrance16.  In this study, two transi-
tion polymorphisms located in the promoter of  IFN-γ R1 
gene at nucleotides – 56 (replacement of  C by T) and – 
611(replacement of  A by G) were selected for evaluation 
of  their relation to susceptibility for human brucellosis. 
The IFN-γ contributed to control of  the infection. This 
has been demonstrated with Brucella abortus by show-
ing that supplementing BALB/c mice with recombinant 
IFN-γ enhanced resistance resulting in a 10-fold decrease 
in the number of  bacteria at one week after infection. 
Also, it has been shown that depleting IFN-γ by the ad-
ministration of  monoclonal antibodies which neutralized 
IFN-γ resulted in a 10-fold increase in the number of  
bacteria 1 week post-infection21. Polymorphisms affecting 
cytokines controlling the immune response against infec-
tious diseases could be the potential markers of  suscepti-
bility and clinical outcome of  different infectious diseases 
in humans22. In this study, both tested polymorphisms, 
IFN-γ R1 – 56 C>T polymorphism and IFN-γ R1 – 611 
A>G polymorphism had no role in genetic susceptibility 
Table 2: Assessment of association of IFN-γ R1 – 611 A>G polymorphism and Brucellosis patients. 
 
Model Brucellosis patients (n = 69) 
Healthy 
control 
(n = 96) 
P value 
(Pearson) Odd ratio (95% CI) 
Co-dominant     
0.260 
  
A/A 36(52%) 49(51%)   
A/G 25(36%) 37(39%)   
G/G 8(12%) 10(10%) 0.999(0.632 – 1.644) 
Allelic effect 
A 0.70 0.70     
G 0.30 0.30 0.936 0.981 (0.608 – 1.582) 
Over-dominant         
A/A-G/G 44(64%) 59(61.5%)   1.00 
A/G 25(36%) 37(38.5%) 0.742 0.895 (0.461 – 1.737) 
Recessive         
A/A - A/G 61(88.4%) 86(89.6%)   1.00 
G/G 8(11.6%) 10(10.4%) 0.835 0.901 (0.336 – 2.414) 
Dominant         
A/A 36(52%) 49(51%)   1.00 
A/G - G/G 33(48%) 47(49%) 0.817 0.930 (0.502 – 1.723) 
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to human Brucellosis and the significant association was 
not present. There are various possible interpretations of  
these findings. The effects of  IFN-γ R1 polymorphisms 
on Brucella might be too small to be detected with this 
sample size, or might affect only a sub-phenotype of  se-
vere Brucella. It was likely that the genetic basis of  sus-
ceptibility to Brucella is built upon many different pro-
tective genes, each individually resulting in small effects23. 
Similar results were reported by using other protective 
genes such as TNF-α-857C/T polymorphism against 
human brucellosis16. Furthermore, another study did not 
observe any significant associations between the IRF1 
polymorphisms or haplotypes analyzed and susceptibility 
to severe disease in any of  the study populations24.
Interestingly, screening of  IFN-γ R1 – 611 A>G poly-
morphism by PCR-CTPP gave good genotyping results 
(Fig. 4 and Table 2). We have designed a PCR-CTPP 
method to be used for genotyping of     IFN-γ R1 – 611 A 
> G polymorphism (see materials and methods section). 
It is time-saving, easy to perform and inexpensive. It can 
be used for genotyping of  most types of  mutation17.
Conclusion
Interestingly, we have developed a PCR-CTPP system to 
be used for genotyping of     IFN-γ R1 – 611 A > G poly-
morphism. The PCR-CTPP is an accurate method for 
genotyping of  SNPs. Moreover, it is time-saving, inex-
pensive and easy to perform. Both tested polymorphisms, 
IFN-γ R1 – 56 C>T polymorphism and IFN-γ R1 – 611 
A>G polymorphism had no rule in genetic susceptibili-
ty to human Brucellosis in study population. Further in-
sights could be gained by conducting fine mapping stud-
ies in multiple populations of  larger sample size, where 
both phenotypes, Brucella load and disease severity, could 
be inspected against the same genetic background.
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